top of page

ultrasensitive detection of disease and biomarkers

10X Higher Sensitivity than
the Clinical Reference Lab

... results in 12 minutes at the Point-of-Care

... results in 12 minutes at the Point-of-Care

Ultra-high sensitivity immunoassays and blood chemistry - one platform

Phoenix Instrument NoBackground with Badge.png

Point-of-Care Platform

Sensitivity: LoD 0.20 ng/L (Cardiac Troponin I)
Multiplex: Cardiac panel (cTnI, NT-proBNP, D-dimer)
Time-to-Result: 11.3 min. 1-2 plex, 12.8 min. 3-4 plex
Blood Chemistry: Chem 7 panel in development
Low-cost cartridge and consumables
Room temperature reagent shipping and storage
Broad menu of immunoassays available
Comprehensive run-time QC with each sample

Novilux Highlights

Strong IP portfolio
Proven platform technology
More than 50 SMC™ immunoassay kits developed (RUO)
- Cardiology, Oncology, Neurology, Autoimmune and infectious disease
Strategic out-licenses completed to grow the business
- Ecosystem of new biomarker development in place
- Royalty bearing license in orthogonal market
Experienced team
Point-of-Care Platform - poised for commercialization

confocal optics Fade 3.png

Single Molecule Counting - SMC™

Immunoassay process.jpg

Single Molecule Counting Technology

Disc 001_edited.jpg

Consumables

Ab graphic 3.png

Assays

Brain Black Background.jpg

Intellectual Property & Out-Licensing

Final Render - 01.png

Instruments

Team Shot Transparent.jpg.png

Meet the Team

bottom of page